■介绍一项调查的结果,该调查涉及中国97个集中静脉内混合剂服务(CIVAS)中心,以回顾中国VAS的最新进展。
■通过电子邮件问卷对中国一级或二级医院的103CIVAS中心进行了调查。
■97个中心回应(回应率94%)。关于规模和产出问题,每天产量超过10,000袋的largeCIVAS中心占10%,而每个工作台和每平方米的产量在不同中心之间差异很大。对于人员结构,80%的CIVAS中心选择了药学和护理相结合的模式。对于CIVAS操作模型,超过80%的中心采用药物集中复合模式。
■CIVAS中心在中国医院药房中发挥着重要作用,并已发展成为新兴的制药行业。ChineseCIVAS中心的发展变化很大。关于人员结构,建议采用药学-护理相结合的模式,而运营模式应根据具体医院进行选择。迫切需要CIVAS操作和人员培训的通用准则。
UNASSIGNED: To present the results of a survey involving 97 centralised intravenous admixture service (
CIVAS) centres in China to review the recent advances of Chinese
CIVAS.
UNASSIGNED: 103 CIVAS centres in first- or second-class Chinese hospital settings were surveyed by email questionnaire.
UNASSIGNED: Ninety-seven centres responded(response rate 94%). With regard to scale and output issues, large CIVAS centres with a daily output of more than 10 000 bags accounted for 10% while the per workbench and per square metre output varied dramatically among different centres. For personnel structure, 80% of
CIVAS centres chose the combination model of pharmacy and nursing. For the CIVAS operation model, more than 80% of centres adopted the drug centralised compounding model.
UNASSIGNED: CIVAS centres are playing an important role in Chinese hospital pharmacy and have developed into an emerging pharmaceutical industry. The development of Chinese
CIVAS centres is very variable. With regard to the personnel structure, the pharmacy-nursing combination model is recommended, while the operation model should be selected according to specific hospitals. Universal guidelines for
CIVAS operation and personnel training are urgently needed.